TherapeuticsMD shareholders approve all proposals including share authorization increase to 640M

TherapeuticsMD, Inc.

Four director nominees elected: Thompson, Collins, Naughton, Roberts; each received >5.1M for votes.
Advisory say-on-pay approved: 5.16M for, 81.6K against, 8.3K abstain.
Advisory vote on frequency: 1-year chosen (5.18M votes); board adopts annual advisory vote.
Ratification of Berkowitz Pollack Brant as FY2025 auditor approved: 6.77M for, 42.2K against.
Amendment to increase authorized common shares to 640M approved: 6.27M for, 548.9K against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.